These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6113285)

  • 61. Synthesis of new water-soluble dihydropyridine vasodilators.
    Iwanami M; Shibanuma T; Fujimoto M; Kawai R; Tamazawa K; Takenaka T; Takahashi K; Murakami M
    Chem Pharm Bull (Tokyo); 1979 Jun; 27(6):1426-40. PubMed ID: 544055
    [No Abstract]   [Full Text] [Related]  

  • 62. Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.
    Bai R; Huang X; Yang X; Hong W; Tang Y; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
    Bioorg Med Chem; 2013 May; 21(9):2495-502. PubMed ID: 23538234
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
    Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
    J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.
    Basil B; Clark JR; Coffee EC; Jordon R; Loveless AH; Pain DL; Wooldridge KR
    J Med Chem; 1976 Mar; 19(3):399-402. PubMed ID: 3647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Synthesis and beta-adrenergic blocking activity of 1-amino-3-(1,3-dioxalan-2-ylphenyloxy) propan-2-ols and 1-amino-3-(183-dioxan-2-ylphenyloxy)-propan-2-ols (author's transl)].
    Janiak PS; Moser U; Mutschler E
    Arch Pharm (Weinheim); 1978 Feb; 311(2):131-5. PubMed ID: 25640
    [No Abstract]   [Full Text] [Related]  

  • 66. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
    Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties.
    Wu ES; Cole TE; Davidson TA; Dailey MA; Doring KG; Fedorchuk M; Loch JT; Thomas TL; Blosser JC; Borrelli AR
    J Med Chem; 1989 Jan; 32(1):183-92. PubMed ID: 2909730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 69. Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    McClure DE; Baldwin JJ; Randall WC; Lyon TF; Mensler K; Lundell GF; Raab AW; Gross D; Risley EA; Sweet CS; Williams M
    J Med Chem; 1983 May; 26(5):649-57. PubMed ID: 6132999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
    Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
    J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
    Smith LH; Tucker H
    J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultra-short-acting beta-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function.
    Erhardt PW; Woo CM; Matier WL; Gorczynski RJ; Anderson WG
    J Med Chem; 1983 Aug; 26(8):1109-12. PubMed ID: 6135805
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
    Gombar V
    Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
    [TBL] [Abstract][Full Text] [Related]  

  • 76. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.
    Tucker H; Coope JF
    J Med Chem; 1978 Aug; 21(8):769-73. PubMed ID: 29123
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
    Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
    [No Abstract]   [Full Text] [Related]  

  • 79. [The synthesis of beta receptor blocking substances].
    Bercher H; Ehlers D; Grisk A
    Pharmazie; 1976 Jun; 31(6):351-4. PubMed ID: 8792
    [No Abstract]   [Full Text] [Related]  

  • 80. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.